Evidence map›Paper›PMID 33277282›Full record

ArticleBMJ open2020

US veterans administration diabetes risk (VADR) national cohort: cohort profile.

Sanja Avramovic, Farrokh Alemi, Rania Kanchi, Priscilla M Lopez, Richard B Hayes, Lorna E Thorpe, Mark D Schwartz

Abstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Improving Diabetic Kidney Disease Screening in Veterans Affairs Primary Care Clinics.Clinical diabetes : a publication of the American Diabetes Association · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sanja AvramovicHealth Administration and Policy, George Mason University, Fairfax, Virginia, USA savramov@gmu.edu.ORCID 0000-0002-6155-9241
Farrokh AlemiHealth Administration and Policy, George Mason University, Fairfax, Virginia, USA.
Rania KanchiDepartment of Population Health, New York University School of Medicine, New York, New York, USA.
Priscilla M LopezDepartment of Population Health, New York University School of Medicine, New York, New York, USA.
Richard B HayesDepartment of Population Health, New York University School of Medicine, New York, New York, USA.
Lorna E ThorpeDepartment of Population Health, New York University School of Medicine, New York, New York, USA.
Mark D SchwartzVA New York Harbor Healthcare System, New York, New York, USA.

Funding

Component A: Impact of Community Factors on Geographic Disparities in Diabetes and Obesity NationwideU01DP006299 · DP · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI THORPE, LORNA · 2017 to 2021
$4.1M
ACL HHS U01DP006299NCCDPHP CDC HHS U01 DP006299
6 · The paper itself

Abstract

purposeThe veterans administration diabetes risk (VADR) cohort facilitates studies on temporal and geographic patterns of pre-diabetes and diabetes, as well as targeted studies of their predictors. The cohort provides an infrastructure for examination of novel individual and community-level risk factors for diabetes and their consequences among veterans. This cohort also establishes a baseline against which to assess the impact of national or regional strategies to prevent diabetes in veterans.

participantsThe VADR cohort includes all 6 082 018 veterans in the USA enrolled in the veteran administration (VA) for primary care who were diabetes-free as of 1 January 2008 and who had at least two diabetes-free visits to a VA primary care service at least 30 days apart within any 5-year period since 1 January 2003, or veterans subsequently enrolled and were diabetes-free at cohort entry through 31 December 2016. Cohort subjects were followed from the date of cohort entry until censure defined as date of incident diabetes, loss to follow-up of 2 years, death or until 31 December 2018. FINDINGS TO DATE: The incidence rate of type 2 diabetes in this cohort of over 6 million veterans followed for a median of 5.5 years (over 35 million person-years (PY)) was 26 per 1000 PY. During the study period, 8.5% of the cohort were lost to follow-up and 17.7% died. Many demographic, comorbidity and other clinical variables were more prevalent among patients with incident diabetes. FUTURE PLANS: This cohort will be used to study community-level risk factors for diabetes, such as attributes of the food environment and neighbourhood socioeconomic status via geospatial linkage to residence address information.

Indexed as

Diabetes Mellitus, Type 2VeteransAdolescentAdultAgedAged, 80 and overComorbidityFemaleHumansMaleMiddle AgedRetrospective StudiesUnited StatesUnited States Department of Veterans AffairsYoung Adultepidemiologygeneral diabeteshealth informatics

Identifiers

PMID33277282
PMCPMC7722386

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.